4.7 Article

Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies

期刊

BRITISH JOURNAL OF CANCER
卷 112, 期 9, 页码 1585-1593

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2015.90

关键词

Human papillomavirus (HPV); MSM; sexual health clinic; genitourinary medicine clinic; immunisation; cross-sectional survey

类别

资金

  1. National Institute of Health Research (NIHR)
  2. Medical Research Council (MRC)
  3. MRC [G0701757] Funding Source: UKRI
  4. Medical Research Council [G0701757] Funding Source: researchfish

向作者/读者索取更多资源

Background: Human papillomavirus (HPV) vaccination of girls will have relatively little effect on HPV-related disease in men who have sex with men (MSM). We determined HPV prevalence and risk factors in MSM to inform the potential effectiveness of vaccinating MSM. Methods: Cross-sectional study of 522 MSM aged 18-40 attending a London sexual health clinic who completed a computer-assisted self-interview. Urine and two swabs (anal and penile/scrotal/perianal) were collected and tested using an in-house Luminex-based HPV genotyping system. Results: Prevalence of DNA of the vaccine-preventable HPV types in ano-genital specimens of men was 87/511 (17.0%), 166/511 (32.5%) and 232/511 (45.4%) for the bivalent (HPV16/18), quadrivalent (HPV6/11/16/18) and nonavalent (HPV6/11/16/18/31/33/45/ 52/58) vaccine types, respectively. A total of 25.1% had one of the quadrivalent types, and 7.4% had 2+ types. Median age at first anal sex was 19 (IQR 17-23) and at first clinic attendance was 24 (IQR 20-27). The increase in the odds of any HPV infection per year of age was 4.7% (95% CI 1.2-8.4). Conclusions: On the basis of the current infection status, most MSM, even among a high-risk population attending a sexual health clinic, are not currently infected with the vaccine-type HPV. A targeted vaccination strategy for MSM in the UK could have substantial benefits.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries

Abraham M. Getaneh, Xiao Li, Zhuxin Mao, Caroline K. Johannesen, Elisa Barbieri, Jojanneke van Summeren, Xin Wang, Sabine Tong, Eugenio Baraldi, Emily Phijffer, Caterina Rizzo, Maarten van Wijhe, Terho Heikkinen, Louis Bont, Lander Willem, Mark Jit, Philippe Beutels, Joke Bilcke

Summary: This study evaluates the cost-effectiveness of potential mAb and MI interventions against RSV in infants in six European countries. The results show that the choice between MI or mAb depends on factors such as protection level, price, and feasibility for different countries and scenarios.

VACCINE (2023)

Article Economics

Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study

Xiao Li, David Hodgson, Julien Flaig, Alexia Kieffer, William L. Herring, Hadi Beyhaghi, Lander Willem, Mark Jit, Joke Bilcke, Philippe Beutels

Summary: This study compared static and dynamic models to analyze the cost-effectiveness of maternal vaccine (MV) and monoclonal antibody (mAb) interventions against respiratory syncytial virus (RSV). The static models estimated fewer medically attended cases averted, but showed significant cost savings and quality-adjusted life years (QALYs) gained. On the other hand, the dynamic models estimated more cases averted, especially non-medically attended cases. These differences can be explained by the model types and assumptions on non-medical burden and intervention effectiveness over time.

VALUE IN HEALTH (2023)

Article Medicine, General & Internal

Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: a modelling study

Tingting You, Xuelian Zhao, Shangying Hu, Meng Gao, Yang Liu, Yong Zhang, Youlin Qiao, Mark Jit, Fanghui Zhao

Summary: The key barrier to cervical cancer elimination in China is low HPV vaccine uptake due to supply constraints, high prices, and dose restrictions. This study explores optimal vaccination strategies for maximizing health and economic benefits under different supply and dose schedules.

ECLINICALMEDICINE (2023)

Article Infectious Diseases

Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study

Yumeng Du, Chenqi Jin, Mark Jit, Tracey Chantler, Leesa Lin, Heidi J. Larson, Jing Li, Wenfeng Gong, Fan Yang, Nina Ren, Weibin Cheng, Yi Zhou, Weiming Tang, Joseph D. Tucker, Dan Wu

Summary: This study aimed to understand the factors associated with influenza vaccine uptake among children and older people in China. The results showed that the vaccination rate was higher in the subsidized group compared to the self-paid group. In the self-paid group, prior vaccination experiences and trust in providers' advice were associated with higher vaccine uptake, while in the subsidized group, marital status, perception of vaccine effectiveness, and previous experience of influenza-like illnesses in the family were associated with vaccine uptake.

BMC INFECTIOUS DISEASES (2023)

Article Medicine, General & Internal

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis

Horace C. W. Choi, Kathy Leung, Karen K. L. Chan, Yuan Bai, Mark Jit, Joseph T. T. Wu

Summary: This study aimed to evaluate the cost-effectiveness of determining the optimal screening strategies for vaccinated and unvaccinated cohorts. It found that HPV testing is a cost-effective alternative to cytology for vaccinated cohorts, and the optimal screening frequency depends on vaccine uptake.

BMC MEDICINE (2023)

Article Medicine, General & Internal

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa

Mihaly Koltai, Jocelyn Moyes, Bryan Nyawanda, Joyce Nyiro, Patrick K. Munywoki, Stefano Tempia, Xiao Li, Marina Antillon, Joke Bilcke, Stefan Flasche, Philippe Beutels, D. James Nokes, Cheryl Cohen, Mark Jit

Summary: Respiratory syncytial virus (RSV) causes a significant burden of acute lower respiratory infection in children under 5 years, especially in low- and middle-income countries. Maternal vaccine (MV) and next-generation monoclonal antibody (mAb) candidates have shown effectiveness in reducing RSV disease. Original hospital-based data from South Africa and Kenya suggest that interventions against RSV disease may be more cost-effective than previously estimated.

BMC MEDICINE (2023)

Article Medicine, General & Internal

Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT)

Emily Herrett, Keith Tomlin, Liang-Yu Lin, Laurie A. Tomlinson, Mark Jit, Andrew Briggs, Michael Marks, Frank Sandmann, John Parry, Christopher Bates, Jessica Morley, Seb Bacon, Benjamin Butler-Cole, Viyaasan Mahalingasivam, Alan Dennison, Deb Smith, Ethan Gabriel, Amir Mehrkar, Ben Goldacre, Liam Smeeth, Rosalind M. M. Eggo

Summary: This study aims to understand the impact of long COVID on health-related quality of life and productivity in English primary care patients. Participants will be asked to complete questionnaires through a smartphone app, covering aspects such as HRQoL, productivity, and symptoms of long COVID. Analysis will be conducted using the OpenSAFELY data platform to estimate the impact on HRQoL, productivity, and cost to the NHS.

BMJ OPEN (2023)

Article Medicine, General & Internal

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness

Simon Procter, Bronner P. Goncalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond Hutubessy, Caroline Trotter, Joy E. Lawn, Mark Jit

Summary: This study assessed the health impact and cost-effectiveness of GBS maternal vaccination globally. The results showed that a GBS maternal vaccination program could significantly reduce the burden of infant mortality and disability, and it is a cost-effective intervention.

PLOS MEDICINE (2023)

Article Medicine, General & Internal

Estimating the full health and economic benefits of current and future influenza vaccines

Naomi R. Waterlow, Simon R. Procter, Rosalind M. Eggo, Mark Jit

Summary: In a recent study, we examined the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya. A commentary on our study highlights the broader benefits of vaccination on cost-effectiveness. While we agree with many points raised in the commentary, it raises interesting discussion points on model complexity, assumptions, and data availability, which have implications beyond this specific study.

BMC MEDICINE (2023)

Article Medicine, General & Internal

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis

Kiesha Prem, Yoon Hong Choi, Elodie Benard, Emily A. Burger, Liza Hadley, Jean-Francois Laprise, Mary Caroline Regan, Melanie Drolet, Stephen Sy, Kaja Abbas, Allison Portnoy, Jane J. Kim, Marc Brisson, Mark Jit

Summary: Using three independent HPV transmission models, the study estimated the long-term health benefits and cost-effectiveness of one-dose versus two-dose HPV vaccination. Results showed that one-dose vaccination had similar health benefits to a two-dose programme and could prevent millions of cervical cancer cases. The cost of the second dose was relatively low across all income groups.

BMC MEDICINE (2023)

Article Medicine, General & Internal

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making

Raymond Hutubessy, Jeremy A. Lauer, Birgitte Giersing, So Yoon Sim, Mark Jit, David Kaslow, Siobhan Botwright

Summary: The Full Value of Vaccines Assessments (FVVA) framework provides guidance for assessing and communicating the value of vaccines, addressing economic obstacles and promoting investment in vaccines. It aims to enhance decision-making and coordination among stakeholders, leading to more sustainable and equitable impacts of vaccines.

BMC MEDICINE (2023)

Article Immunology

Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022

Meagan C. Fitzpatrick, Rachel S. Laufer, Ranju Baral, Amanda J. Driscoll, Daniel R. Feikin, Jessica A. Fleming, Mark Jit, Sonnie Kim, Mihaly Koltai, You Li, Xiao Li, Harish Nair, Kathleen M. Neuzil, Clint Pecenka, Erin Sparrow, Padmini Srikantiah, Justin R. Ortiz

Summary: Policymakers often rely on impact and cost-effectiveness evaluations to inform decisions about the introduction of health interventions in LMICs; however, cost-effectiveness results for the same health intervention can differ by the choice of parameter inputs, modelling assumptions, and geography. This report summarizes a two-day virtual consultation convened by WHO to review and discuss existing cost-effectiveness analyses for RSV prevention in LMICs, in order to identify influential inputs and data limitations, and recommend future research priorities to improve RSV prevention impact estimates in LMICs.

VACCINE (2023)

Article Medicine, General & Internal

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study

Allison Portnoy, Jean-Louis Arcand, Rebecca A. A. Clark, Chathika K. K. Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G. G. White, Nicolas A. A. Menzies

Summary: This study aimed to estimate the impact of introducing novel TB vaccines on GDP growth in 105 LMICs. The results showed that introducing new TB vaccines could increase economic growth in these countries, with a more significant effect in countries with higher current TB incidence.

PLOS MEDICINE (2023)

Article Medicine, General & Internal

The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach

Marina Antillon, Xiao Li, Lander Willem, Joke C. Bilcke, - C. RESCEU investigators, Mark Jit, Philippe Beutels

Summary: This study aimed to assess the burden of respiratory syncytial virus (RSV) on children under 5 years old. The findings showed that infants under 6 months old, especially in low-income and middle-income countries, are at higher risk of infection, hospitalization, and death. Therefore, the study suggests implementing multiple measures to reduce the burden on this population.

PLOS MEDICINE (2023)

Article Medicine, Research & Experimental

Assessing the impact of the 2018 Changchun Changsheng vaccine incident on childhood vaccination in China

Zhiyuan Hou, Xiaozhen Lai, Yang Liu, Mark Jit, Heidi J. Larson, Hai Fang

Summary: This study assessed the impact of the 2018 Changchun Changsheng vaccine incident on childhood vaccination in China, finding that the vaccine involved in the incident was delayed in its administration, but there was minimal effect on other vaccines.

COMMUNICATIONS MEDICINE (2023)

暂无数据